Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway

Arteriosclerosis, Thrombosis, and Vascular Biology
S SugiyamaH Yasue

Abstract

Lysophosphatidylcholine (lysoPC), which is generated in oxidized LDL (Ox-LDL) and abundantly exists in atherosclerotic arterial walls, has been shown to alter various endothelial functions and induces several endothelial genes expressed in atherosclerotic arterial walls. Nuclear factor-kappa B (NF-kappaB), a pleiotropic transcription factor, plays an important role in regulation of expression of various genes implicated in atherosclerosis. We have previously reported that lysoPC transferred from Ox-LDL to endothelial surface membrane activates endothelial protein kinase C (PKC), leading to modulated endothelial functions. This study was aimed at determining whether lysoPC could modulate activity of transcription factors in cultured human umbilical vein endothelial cells (HUVECs) by using electrophoretic mobility shift assay. LysoPC was found to increase DNA-binding activity of NF-kappaB in HUVECs within 15 minutes, which peaked at 1 to 2 hours and subsequently declined to the baseline level at 6 hours. Lower concentrations (5 to 15 micromol/L) of lysoPC markedly increased NF-kappaB activity, but higher concentration (50 micromol/L) of lysoPC inhibited the activity. Phorbol 12-myristate 13-acetate, a potent activator of PKC, als...Continue Reading

References

May 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·W T ShierN M Thanassi
Dec 1, 1991·The Journal of Clinical Investigation·J L Witztum, D Steinberg
Aug 23, 1990·Nature·J DownwardD A Cantrell
Nov 15, 1990·Biochemical and Biophysical Research Communications·J M HerbertJ P Maffrand
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S Parthasarathy, J Barnett
Mar 15, 1989·Biochemical and Biophysical Research Communications·E KobayashiT Tamaoki
Feb 15, 1983·Archives of Biochemistry and Biophysics·G W BurtonK U Ingold
Feb 23, 1995·The American Journal of Cardiology·M A Gimbrone
Sep 1, 1995·The Journal of Clinical Investigation·A ZembowiczK K Wu
Sep 8, 1995·The Journal of Biological Chemistry·H M LanderA Novogrodsky
Jun 23, 1995·The Journal of Biological Chemistry·V V KravchenkoR D Ye
Feb 24, 1995·Cell·D Thanos, T Maniatis
Jan 1, 1994·Annual Review of Cell Biology·U SiebenlistK Brown
Aug 1, 1993·The Journal of Clinical Investigation·H F McMurrayD Steinberg
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·S Li, J M Sedivy
Apr 1, 1996·The Journal of Clinical Investigation·K BrandD Neumeier
Jan 1, 1996·Annual Review of Immunology·A S Baldwin

❮ Previous
Next ❯

Citations

Aug 5, 2000·Free Radical Biology & Medicine·G LeonarduzziG Poli
Jun 24, 2003·The International Journal of Biochemistry & Cell Biology·André L FulyJorge A Guimarães
Jan 18, 2003·Biochimica Et Biophysica Acta·Robert SalvayreAnne Negre-Salvayre
Jul 9, 1999·Biochimica Et Biophysica Acta·A Wang, E A Dennis
Jun 21, 2008·Cell Death and Differentiation·E M YazlovitskayaD E Hallahan
Mar 13, 2002·Annals of Periodontology·T C NicholsA S Baldwin
Jun 8, 2011·Future Medicinal Chemistry·Jeffrey M Craft, Dennis Hallahan
Feb 22, 2005·Biochemical and Biophysical Research Communications·Abdullah Md SheikhJunichi Masuda
Sep 11, 2007·Molecular Aspects of Medicine·Adelina Munteanu, Jean-Marc Zingg
Feb 24, 2007·Molecular Aspects of Medicine·Elke ReiterStephan Christen
Oct 2, 2008·The British Journal of Nutrition·S Honarbakhsh, M Schachter
Aug 28, 2001·Journal of Atherosclerosis and Thrombosis·S TakeshitaM Yokoyama
Mar 15, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Fei HuangHazel Lum
Nov 13, 1998·Current Opinion in Lipidology·B L Thurberg, T Collins
Jan 17, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Frank RoseHossein Ardeschir Ghofrani
Sep 29, 2000·American Journal of Physiology. Heart and Circulatory Physiology·R C LiR Bolli
Sep 7, 2004·Free Radical Research·Fanny RobbesynAnne Negre-Salvayre
Jun 19, 2001·American Journal of Physiology. Heart and Circulatory Physiology·Y RikitakeM Yokoyama
Feb 22, 2001·Journal of the American Society of Nephrology : JASN·Kathrin HeermeierJan Galle
Jun 1, 2007·Toxicon : Official Journal of the International Society on Toxinology·André L FulyVera Lucia G Koatz
Jun 10, 2004·Journal of Agricultural and Food Chemistry·Nianbai FangThomas M Badger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.